Role of complement mediated pulmonary leukostasis
Craddock et al have suggested that hypoxemia is cause by plugging of pulmonary vessels with leukocytes during hemodialysis with cellophane dialyzers (2, 6) . A marked but transient leukopenia, almost exclusively due to a reduction in circulating neutrophilic granulocytes and monocytes, is noted shortly after the onset of dialysis (2, (6) (7) (8) (9) . In a series of elegant in vitro and in vivo studies, Craddock et al have shown that this granulocytopenia and monocytopenia are due to intense pulmonary leukostasis, a process mediated by a cellophane-activated complement component, specifically C5a. They also observed a marked hypoxemia which was accompanied by an increased alveolar-arterial oxygen gradient (A-aD02), reduced DLCO, and increased closing volume. In addition, increased pulmonary arterial pressure and increased pulmonary lymph formation were noted in experimental animals infused with cellophaneincubated autologous plasma. Unlike normal animals, granulocytopenic animals failed to develop hypoxemia in response to infusion of cellophaneincubated autologous plasma. Similarly, no hypoxemia was noted during dialysis in a patient with severe granulocytopenia (2) . Based on these observations Craddock et al concluded that hemodialysis-induced hypoxemia and pulmonary function abnormalities are due to impaired gas exchange associated with intense pulmonary leukostasis. This was 8 further supported by the subsequent observation that the magnitude of dialysis-induced granulocytopenia closely correlates with the severity of the associated hypoxemia and the fall in DLCO (10) . In a recent study of euvolemic patients with end-stage renal failure we noted a significant reduction of pulmonary capillary blood flow following dialysis (11) . This observation tends to support the contribution of pulmonary vascular obstruction in causing dialysis hypoxemia. Yet while pulmonary leukostasis appears to provide a satisfactory explanation for dialysis hypoxemia and the associated pulmonary dysfunction, several observations tend to contradict this hypothesis: a) -Despite resolution of leukopenia and pulmonary leukostasis within 1-2 hours, hypoxemia persists through dialysis and for several hours thereafter. This, however, can be due to secretion by the aggregated granulocytes of certain active substances capable of affecting pulmonary circulation and airway function, even after the resolution of leukostasis. b) -Hypoxemia regularly occurs during hemodialysis with polyacrylonitrile (PAN), polysulfon, and reused cellulose-based dialyzers, which do not cause significant leukopenia (2, 13) . c) -Dialysis-induced hypoxemia is mitigated or prevented by bicarbonate-buffered or C02-bubbled dialysates despite the development of leukopenia (14, 15) . d) -In sequential hemofiltration and hemodialysis, leukopenia occurs during hemofiltration without hypoxemia. The latter becomes manifest during the subsequent dialysis despite the resolution of leukopenia (12) . e) -Increased A-aD02 demonstrated in the earlier studies was based on the assumption that alveolar oxygen tension (PA02) remains constant during dialysis.
Subsequent studies in which PA02 was determined have shown a concomitant reduction of PA02 and pa02 with no change in A-aD02 (4, 12, 14) . Reduction in PA02, which is mathematically a function of lung C02 excretion and oxygen consumption, can be explained by the demonstrated fall in lung C02 excretion and increased 02 consumption. A perfusion defect is therefore unlikely to be the main cause of the hypoxemia which could be adequately explained by reduced PA02.
Role of hypoventilation
Dissociation of dialysis-induced leukopenia from hypoxemia, demonstrated in the above examples, suggests that these phenomena may represent two unrelated effects of hemodialysis. In a recent study, Patterson et al showed that dialysis hypoxemia was associated with a fall in minute ventilation and alveolar oxygen tension (PA02) and no change in arterial PC02 and A-aD02 (4). These observations are consistent with earlier findings by Sherlock et al, who found a fall in PA02 with constant A-aD02 during dialysis (15) , as well as a fall in pulmonary C02 excretion with no change in PaC02. These findings are indicative of the primary role of hypoventilation in the genesis of hypoxemia. This hypoventilation could somehow be mediated by a fall in central venous PC02 due to C02 losses across the dialyzer (4, 12, 15) -a hypothesis consistent with the observed fall of total and alveolar ventilation in spontaneously breathing dogs when C02 is removed by artificial lung (16) . The presence of a possible C02chemoreceptor on the venous side has been suggested by Kollmeyer and Kleinman, who have demonstrated that when venous PC02 is altered by extracorporeal means in dogs, the ventilation changes so as to maintain the arterial PC02 constant (17) . A clinical corollary to these experimental models is post-hyperventilation hypoxia in which restoration of the depleted C02 stores leads to a transient fall in venous PC02 (18) .
Role of oxygen consumption (\102)
A marked increase in \/02 has been shown to occur during hemodialysis (4, 15) . Its mechanism is not clear, although acetate metabolism has been implicated as a possible reason. It is of interest, however, that Sherlock et al noted a moderate but significant rise in \/02 while dialysate flow was off (15) . This observation suggests that additional mechanisms must be operative.
Role of dialysate composition
A number of clinical and animal studies have suggested that the acetate content of the conventional dialysates plays a major role in causing hypoxemia. Ikeda et al demonstrated a fall in Pa02 following intravenous infusion of Na-acetate to patients with end-stage renal disease. The administration of an equal amount of Nabicarbonate, however, did not alter Pa02 appreciably, nor did NaCI administration (19) . The effects of the administered acetate and bicarbonate on PC02, plasma bicarbonate, and pH were comparable. The blood gas changes observed by Ikeda et al following acetate administration are consistent with earlier observations in experimental animals (20, 21) . It is therefore apparent that acetate can cause hypoxemia by some as yet unclear mechanism. Interestingly, triggering of asthma attacks by acetate hemodialysis has been reported by Aljama (22) and Ei (19) . Replacing acetate dialysate by bicarbonate dialysate led to disappearance of asthma attacks in the case reported by Ei et al.
In addition to a possible direct effect, acetate dialysis can cause hypoxemia by two other mechanisms: a) -increased oxygen consumption necessitated by acetate metabolism, and b) -unopposed clearance of C02 across the dialyzer, which can result in hypoventilation. The latter possibility is supported by the observation that dialysis hypoxemia can be abolished or ameliorated when dialyzer C02 loss is diminished by bubbling C02 through the acetate based dialysate (15) . Dialysis with the sorbent system is generally associated with a net gain of C02 through the dialyzer due to the generation of C02 within the system. Using the sorbent system with either acetate or bicarbonate dialysates, Rhomer et al found minimal or no hypoxemia (23) . They suggested that the added C02 leads to hyperventilation which blunts or reverses the dialysis hypoxemia. Hypoxemia does not occur during dialysis with bicarbonate-based dialysates used in single pass delivery systems (14, 20, 24) . This is in part due to the lack of clearance and even net gain of C02 across the dialyzer, which obviates the dialysis-induced hypoventilation.
Role of the dialyzer membrane
From the available data it is evident that single pass hemodialysis with conventional acetate-based dialysates is generally associated with hypoxemia irrespective of the dialyzer membrane used. Jacob et al have found a similar degree of hypoxemia during dialysis with cuprophone, regenerated cellulose, cellulose acetate, and polyachrylonitrile membranes (25) . However, the effects of these membranes on the leukocyte count were markedly different, with cuprophane producing the most and polyachrylonitrile the least changes. A similar observation was made by Dulmer et al, who, in addition to the above membranes, utilized reused-cellulose dialyzers which caused hypoxemia without leukocyte changes (12) . Moreover, they noted a marked leukopenia during hemofiltration with cellulose-based dialyzers but not significant hypoxemia. Based on these observations it is evident that dialysis hypoxemia is independent of the type of dialyzer membrane.
Role of alkalinization
A rise in blood pH could lower arterial blood oxygen tension by two mechanisms: a) -direct suppression of respiratory center resulting in hypoventilation, and b)increased hemoglobin affinity for oxygen (Bohr effect) leading to a reduction of its dissolved fraction i.e. Pa02.
In a series of studies using anesthetized dogs under controlled mechanical respiration, Wathen et al observed a marked hypoxemia along with severe metabolic alkalosis following intravenous infusion on Na-acetate and Na-bicarbonate (21) . They attributed the observed fall of Pa02 which had occurred despite controlled ventilation to the increased hemoglobin affinity for oxygen caused by the associated alkalosis. This was further supported by their in vitro studies on dog blood. The authors further suggested that a similar mechanism may be responsible for dialysis-induced hypoxemia. It should be noted, however, that massive quantities of Na-acetate and Na-bicarbonate (10 mEq/Kg/hr) leading to severe alkalosis were used in these experiments. In contrast, the magnitude of net buffer delivery and the resultant changes of blood pH and bicarbonate concentration during routine dialysis are relatively small. The role of the Bohr effect in the genesis of dialysis-induced hypoxemia is therefore negligible (14) .
In conclusion, hypoxemia commonly occurs during hemodialysis. It is usually asymptomatic, but may cause serious consequences in patients with cardiopulmonary or collagen vascular disorders. The pathogenesis of dialysis hypoxemia is unclear and multiple factors are probably involved. Fluid overloaded patients may exhibit hypoxemia which is expected to improve with ultrafiltration during dialysis but may transiently worsen from superimposed dialysis hypoxemia. Use of bicarbonatebased dialysates, C02-bubbled dialysate or sorbent regeneration system, and oxygen administration can ameliorate or prevent dialysis hypoxemia.
